China Conjugate Vaccine Market-- Overview, Share, Scope, Revenue, Trends, Drivers, Challenges, Segmentation based on Products till 2023

China Conjugate Vaccine Market:

The China Conjugate Vaccine Market report provides an in-depth analysis of the Healthcare & Pharmaceuticals during the forecast period 2018-2023 which consists of the industry overview including the market size, volume, growth rate and recent trends and developments in the market based on historical and current data. The report covers detailed information about the key players, market segments, growth drivers and restraints in the industry. The report delivers an insight into the China Conjugate Vaccine Market which allows our clients to make informed decisions regarding the growth of their businesses.

Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. China is one of the prominent markets with a significant growth rate for conjugate vaccines.

All Expanded Program on Immunization (EPI) vaccines (including tuberculosis, polio, measles, and diphtheria-tetanus-pertussis (DTP), hepatitis A and B, meningococcal, Japanese encephalitis, rubella and mumps) in China are free and mandatory for school admissions. Immunization clinics in China also offer non-EPI vaccines to children but for a fee (and are not covered by insurance programs), including influenza, varicella, Haemophilus influenza type B (Hib), rotavirus, and pneumococcal vaccines, among others.

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10009584

Market Segmentation:

By disease indication, the market is segmented into:

Pneumococcal
Haemophilus influenza type B
Diphtheria-tetanus-pertussis
Meningococcal
Others
By end user, the market is segmented into:

Paediatric
Adult
Key growth factors:

China is projected to be a significant market for conjugate vaccines during the forecast period. Rapidly increasing geriatric population, rise in consumer awareness, growing disposable income and healthcare expenditure, modernization of healthcare infrastructure, and a growing medical tourism industry will drive the growth of the conjugated vaccines market in China. According to the United Nations, China is ageing more rapidly than almost any country in recent history. This acts as a key driver for adult vaccines, owing to more demand by the geriatric population. Since the toll of pneumococcal disease in China is enormous, pneumococcal vaccination could improve children’s health and save lives and is therefore a prime selection for inclusion in the EPI schedule.

Threats and key players:

The China conjugate vaccine market is expected to have significantly high growth. China has spent tremendous resources on the elimination of measles, but such elimination efforts should be combined with other immunization initiatives, such as educating caregivers about the benefits of other vaccines. The Chinese public is receiving more information about measles than about pneumonia or meningitis. Measles vaccine is free in Shanghai, but pneumococcal vaccine requires payment, which impacts the decision of the public significantly as they are reluctant to pay and get vaccinated.
Major Conjugate Vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.
What’s covered in the report?

1. Overview of the China conjugate vaccine market

2. Market drivers, and challenges in the China conjugate vaccine market

3. Market trends in the China conjugate vaccine market

4. Historical, current and forecasted market size data for China based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume

5. Historical, current and forecasted market size data for China based on end user (paediatric and adult conjugate vaccines) – by revenue and by volume

6. Analysis of the competitive landscape and profiles of major companies operating in the China market

Why buy?

Understand the demand for conjugate vaccines to determine the viability of the market
Develop strategies based on the drivers and trends for each of the segments
Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed
Recognize the key competitors of this market and respond accordingly
Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
Define the competitive positioning by comparing the products and services with the key players in the market

Read More-https://www.marketwatch.com/press-release/china-conjugate-vaccine-market-overview-share-scope-revenuechallenges-segmentation-based-on-products-till-2023-2019-10-04

Contact Us

Name: Kenneth research
Email:sales@kennethresearch.com
Phone: +1 313 462 0609
1412 Broadway,
Suite im 21. Stock, MA111,
New York, NY 10018

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

This release was published on openPR.